Catalyst Wire Dossier Catalyst Wire Dossier

Rivaroxaban (generic)

rivaroxaban · Apotex Corp.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rivaroxaban (generic), covering 2025-05-02 to 2025-05-02. Get the full timeline:

Most recent: FDA Approved: RIVAROXABAN — Original Application (Apotex Corp.)

See pricing